BACKGROUND AND OBJECTIVES: In 2003, the National Kidney Foundation introduced guidelines for the control of parathyroid hormone, calcium, and phosphorus in hemodialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A cohort study was conducted of 22,937 incident hemodialysis patients who were identified from a large national provider between July 1, 2000, and June 30, 2002, and followed through June 30, 2004. Consistent achievement was determined (1) as the simultaneous control of multiple markers over time and (2) as the time in target for each marker during the first year of dialysis. Mortality risk was assessed with Cox proportional hazards models. RESULTS: In the simultaneous control analysis, patients who achieved target for none of the markers had a 51% greater risk for death than those who achieved target for all three markers (reference group). Patients who achieved any target for any single marker had a 35 to 39% higher risk for death, and patients who achieved target for any two of the three markers had a 15 to 21% higher risk for death compared with the reference group. In the time in target analysis, patients with parathyroid hormone in target for 4 quarters had a 25% lower risk for death compared with those who did so for <or=1 quarter (reference group). Patients with calcium in target for 4 quarters had a 14% lower risk, and patients with phosphorus in target for 4 quarters had a 38% lower risk. CONCLUSIONS: Consistent control of the markers of bone metabolism and disease within published targets is a strong predictor of survival in hemodialysis patients.
BACKGROUND AND OBJECTIVES: In 2003, the National Kidney Foundation introduced guidelines for the control of parathyroid hormone, calcium, and phosphorus in hemodialysis patients. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: A cohort study was conducted of 22,937 incident hemodialysis patients who were identified from a large national provider between July 1, 2000, and June 30, 2002, and followed through June 30, 2004. Consistent achievement was determined (1) as the simultaneous control of multiple markers over time and (2) as the time in target for each marker during the first year of dialysis. Mortality risk was assessed with Cox proportional hazards models. RESULTS: In the simultaneous control analysis, patients who achieved target for none of the markers had a 51% greater risk for death than those who achieved target for all three markers (reference group). Patients who achieved any target for any single marker had a 35 to 39% higher risk for death, and patients who achieved target for any two of the three markers had a 15 to 21% higher risk for death compared with the reference group. In the time in target analysis, patients with parathyroid hormone in target for 4 quarters had a 25% lower risk for death compared with those who did so for <or=1 quarter (reference group). Patients with calcium in target for 4 quarters had a 14% lower risk, and patients with phosphorus in target for 4 quarters had a 38% lower risk. CONCLUSIONS: Consistent control of the markers of bone metabolism and disease within published targets is a strong predictor of survival in hemodialysis patients.
Authors: M Gallieni; D Brancaccio; F Antonucci; G Bellinghieri; P Carpani; M Cozzolino; F D'Agostino; G Del Mastro; A Mallamace; B Memoli Journal: Clin Nephrol Date: 2000-03 Impact factor: 0.975
Authors: María D Arenas; Fernando Alvarez-Ude; Vicente Torregrosa; María T Gil; María A Carretón; Analía Moledous; Carlos Nuñez; Ramón Devesa; Begoña Albiach Journal: J Nephrol Date: 2007 Jul-Aug Impact factor: 3.902
Authors: Ming Teng; Myles Wolf; Edmund Lowrie; Norma Ofsthun; J Michael Lazarus; Ravi Thadhani Journal: N Engl J Med Date: 2003-07-31 Impact factor: 91.245
Authors: Geoffrey A Block; Preston S Klassen; J Michael Lazarus; Norma Ofsthun; Edmund G Lowrie; Glenn M Chertow Journal: J Am Soc Nephrol Date: 2004-08 Impact factor: 10.121
Authors: Geoffrey A Block; Ryan D Kilpatrick; Kimberly A Lowe; Wenli Wang; Mark D Danese Journal: Clin J Am Soc Nephrol Date: 2013-09-19 Impact factor: 8.237
Authors: Geoffrey A Block; David C Wheeler; Martha S Persky; Bryan Kestenbaum; Markus Ketteler; David M Spiegel; Matthew A Allison; John Asplin; Gerard Smits; Andrew N Hoofnagle; Laura Kooienga; Ravi Thadhani; Michael Mannstadt; Myles Wolf; Glenn M Chertow Journal: J Am Soc Nephrol Date: 2012-07-19 Impact factor: 10.121
Authors: Emanuel Zitt; Christine Jäger; Alexander R Rosenkranz; Manfred Eigner; Katharina Kodras; Josef Kovarik; Helmut Graf; Frank Pétavy; Sabine Horn; Bruno Watschinger Journal: Wien Klin Wochenschr Date: 2011-01-21 Impact factor: 1.704